NCT01961609 - Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants. | Biotech Hunter

Enrollment

235

Participants

Timeline

Start Date

October 9, 2013

Primary Completion Date

July 12, 2016

Study Completion Date

July 12, 2016

Conditions

Psoriasis

Interventions

BIOLOGICAL

Secukinumab (AIN457)

Secukinumab was supplied in 150mg pre-filled syringes.

Trial Locations (54)

24

Novartis Investigative Site, Dublin

T12 X23H

Novartis Investigative Site, Cork

Unknown

Novartis Investigative Site, Dublin

PL6 8DH

Novartis Investigative Site, Plymouth

E11 1NR

Novartis Investigative Site, London

CM20 1QX

Novartis Investigative Site, Harlow

SW10 9NH

Novartis Investigative Site, London

CT1 3NG

Novartis Investigative Site, Canterbury

SA14 8QF

Novartis Investigative Site, Dafen

M6 8HD

Novartis Investigative Site, Salford

NN1 5BD

Novartis Investigative Site, Cliftonville

NG17 4JL

Novartis Investigative Site, Nottingham

AB25 2ZN

Novartis Investigative Site, Aberdeen

BA21 4AT

Novartis Investigative Site, Yeovil

CF4 4XW

Novartis Investigative Site, Cardiff

WS11 5XY

Novartis Investigative Site, Staffordshire

IP4 5PD

Novartis Investigative Site, Ipswich

GU16 7UJ

Novartis Investigative Site, Frimley

RH1 5RH

Novartis Investigative Site, Surrey

LL18 5UJ

Novartis Investigative Site, Rhyl

CV2 2DX

Novartis Investigative Site, Coventry

DY1 2HQ

Novartis Investigative Site, Dudley

BD5 0NA

Novartis Investigative Site, Bradford

LS7 4SA

Novartis Investigative Site, Leeds

ML6 0JS

Novartis Investigative Site, Airdrie

BA1 3NG

Novartis Investigative Site, Bath

BT9 7AB

Novartis Investigative Site, Belfast

B15 2TT

Novartis Investigative Site, Birmingham

B18 7QH

Novartis Investigative Site, Birmingham

CH2 1UL

Novartis Investigative Site, Chester

DH1 5TW

Novartis Investigative Site, Durham

KY12 OSU

Novartis Investigative Site, Fife

G3 8SJ

Novartis Investigative Site, Glasgow

HU3 2JZ

Novartis Investigative Site, Hull

LA1 4RP

Novartis Investigative Site, Lancaster

LE7 5WW

Novartis Investigative Site, Leicester

L14 3PE

Novartis Investigative Site, Liverpool

N19 5NF

Novartis Investigative Site, London

NW3 2QG

Novartis Investigative Site, London

SE1 9RT

Novartis Investigative Site, London

TS4 3BW

Novartis Investigative Site, Middlesbrough

TW7 6AF

Novartis Investigative Site, Middlesex

NE1 4LP

Novartis Investigative Site, Newcastle upon Tyne

NR4 7UY

Novartis Investigative Site, Norwich

NG7 2UH

Novartis Investigative Site, Nottingham

OX3 7LJ

Novartis Investigative Site, Oxford

BH15 2JB

Novartis Investigative Site, Poole

PO6 6AD

Novartis Investigative Site, Portsmouth

YO12 6QL

Novartis Investigative Site, Scaroborough

DN15 7GB

Novartis Investigative Site, Scunthorpe

ST4 6QG

Novartis Investigative Site, Stoke-on-Trent

SM5 1AA

Novartis Investigative Site, Surrey

LL13 7TD

Novartis Investigative Site, Wrexham

YO31 8HE

Novartis Investigative Site, York